| Harold Thies, MD | |
|
2 Pro Health Plz, Lake Success, NY 11042-1111 | |
| (516) 622-6116 | |
| Not Available |
| Full Name | Harold Thies |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Nephrology |
| Location | 2 Pro Health Plz, Lake Success, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447299540 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 140668 (New York) | Primary |
| Entity Name | Prohealth Care Associates Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275596280 PECOS PAC ID: 4486544186 Enrollment ID: O20040317000468 |
News Archive
How are human and animal diseases in general affected by the climate becoming "wilder, wetter and warmer"? Solveig Jore's doctoral research shows that the tick Ixodes ricinus has spread over larger geographical areas in Norway and that climate and environmental changes, access to host animals and demography affect tick distribution in Norway.
A major landmark study released today by the European College of Neuropsychopharmacology (ECNP) sheds new light on the state of Europe's mental and neurological health.
The University of South Florida and Aetna are launching a ground-breaking study that will examine the influence genetic testing may have on clinical treatment decisions among breast cancer patients and their doctors.
PURE Bioscience, creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that its marketing partner, Richmont Sciences (Richmont), has established distribution of PURE's SDC-based IV-7™ products in the Middle East region. Under this arrangement, PURE sells IV-7 products to Richmont for resale into the Middle East, where the IV-7 water treatment and disinfection products have been registered by the United Arab Emirates-Dubai Municipality. Richmont is initially focusing on distribution of IV-7 Water Treatment™.
Asahi Kasei Corporation, and ZOLL Medical Corporation today jointly announced that Asahi Kasei, Japan's leading diversified chemical manufacturer with businesses in the health care, chemicals & fibers, homes & construction materials, and electronics sectors, has entered into a definitive merger agreement with ZOLL, a manufacturer of resuscitation and critical care devices and related software solutions, pursuant to which Asahi Kasei will acquire ZOLL for approximately $2.21 billion.
› Verified 5 days ago
| Entity Name | Optum Urgent Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285975797 PECOS PAC ID: 8628299518 Enrollment ID: O20141017000598 |
News Archive
How are human and animal diseases in general affected by the climate becoming "wilder, wetter and warmer"? Solveig Jore's doctoral research shows that the tick Ixodes ricinus has spread over larger geographical areas in Norway and that climate and environmental changes, access to host animals and demography affect tick distribution in Norway.
A major landmark study released today by the European College of Neuropsychopharmacology (ECNP) sheds new light on the state of Europe's mental and neurological health.
The University of South Florida and Aetna are launching a ground-breaking study that will examine the influence genetic testing may have on clinical treatment decisions among breast cancer patients and their doctors.
PURE Bioscience, creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that its marketing partner, Richmont Sciences (Richmont), has established distribution of PURE's SDC-based IV-7™ products in the Middle East region. Under this arrangement, PURE sells IV-7 products to Richmont for resale into the Middle East, where the IV-7 water treatment and disinfection products have been registered by the United Arab Emirates-Dubai Municipality. Richmont is initially focusing on distribution of IV-7 Water Treatment™.
Asahi Kasei Corporation, and ZOLL Medical Corporation today jointly announced that Asahi Kasei, Japan's leading diversified chemical manufacturer with businesses in the health care, chemicals & fibers, homes & construction materials, and electronics sectors, has entered into a definitive merger agreement with ZOLL, a manufacturer of resuscitation and critical care devices and related software solutions, pursuant to which Asahi Kasei will acquire ZOLL for approximately $2.21 billion.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Harold Thies, MD 2 Pro Health Plz, Lake Success, NY 11042-1111 Ph: () - | Harold Thies, MD 2 Pro Health Plz, Lake Success, NY 11042-1111 Ph: (516) 622-6116 |
News Archive
How are human and animal diseases in general affected by the climate becoming "wilder, wetter and warmer"? Solveig Jore's doctoral research shows that the tick Ixodes ricinus has spread over larger geographical areas in Norway and that climate and environmental changes, access to host animals and demography affect tick distribution in Norway.
A major landmark study released today by the European College of Neuropsychopharmacology (ECNP) sheds new light on the state of Europe's mental and neurological health.
The University of South Florida and Aetna are launching a ground-breaking study that will examine the influence genetic testing may have on clinical treatment decisions among breast cancer patients and their doctors.
PURE Bioscience, creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that its marketing partner, Richmont Sciences (Richmont), has established distribution of PURE's SDC-based IV-7™ products in the Middle East region. Under this arrangement, PURE sells IV-7 products to Richmont for resale into the Middle East, where the IV-7 water treatment and disinfection products have been registered by the United Arab Emirates-Dubai Municipality. Richmont is initially focusing on distribution of IV-7 Water Treatment™.
Asahi Kasei Corporation, and ZOLL Medical Corporation today jointly announced that Asahi Kasei, Japan's leading diversified chemical manufacturer with businesses in the health care, chemicals & fibers, homes & construction materials, and electronics sectors, has entered into a definitive merger agreement with ZOLL, a manufacturer of resuscitation and critical care devices and related software solutions, pursuant to which Asahi Kasei will acquire ZOLL for approximately $2.21 billion.
› Verified 5 days ago
Vincent Vinciguerra, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: The Monter Cancer Center, 450 Lakeville Road, Lake Success, NY 11042 Phone: 516-734-8954 | |
Lora Weiselberg, Nephrology Medicare: Medicare Enrolled Practice Location: The Monter Cancer Center, 450 Lakeville Road, Lake Success, NY 11042 Phone: 516-734-8963 | |
Steve W Rucker, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4 Ohio Drive, Suite 200, Lake Success, NY 11042 Phone: 516-775-4545 Fax: 516-775-4646 | |
Richard Stark, MD Nephrology Medicare: Medicare Enrolled Practice Location: 1999 Marcus Ave, Ste 120, Lake Success, NY 11042 Phone: 516-466-6611 Fax: 516-466-9582 | |
Ummekalsoom Rahman Malik, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 410 Lakeville Rd, Ste 311, Lake Success, NY 11042 Phone: 516-358-2400 Fax: 516-358-5454 | |
Clifford Cooper, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2 Pro Health Plz, Lake Success, NY 11042 Phone: 516-622-6020 | |
Francisco Antonio Garcia-moreno, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 410 Lakeville Rd, Ste 311, Lake Success, NY 11042 Phone: 516-358-2400 Fax: 516-358-5454 |